{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:08Z","timestamp":1791928868226,"version":"4.3.4"},"reference-count":60,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"2","license":[{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2024,2,13]]},"DOI":"10.1167\/iovs.65.2.27","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T12:31:07Z","timestamp":1707827467000},"page":"27","source":"Crossref","is-referenced-by-count":12,"title":["Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines \u2013 A Pilot Study"],"prefix":"10.1167","volume":"65","author":[{"given":"Martina C.","family":"Herwig-Carl","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University Hospital Bonn, Bonn, Germany"},{"name":"Division of Ophthalmic Pathology, University Hospital Bonn, Bonn, Germany"},{"name":"Centrum for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Bonn, Bonn, Germany"},{"name":"Department of Neurosurgery, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Tischler","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Pelusi","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin U.","family":"Loeffler","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Bonn, Bonn, Germany"},{"name":"Division of Ophthalmic Pathology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Bonn, Bonn, Germany"},{"name":"Centrum for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zeschnigk","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, University Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Landreville","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Otolaryngology-Cervicofacial Surgery, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Auw-Haedrich","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Noberini","sequence":"additional","affiliation":[{"name":"Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Bonaldi","sequence":"additional","affiliation":[{"name":"Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan, Italy"},{"name":"Department of Oncology and Haematology-Oncology (DIPO), University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye (London, England)"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1101\/gad.296962.117","article-title":"Focus on cutaneous and uveal melanoma specificities","volume":"31","author":"Pandiani","year":"2017","journal-title":"Genes Dev"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0046-8177(82)80116-0","article-title":"Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis","volume":"13","author":"McLean","year":"1982","journal-title":"Hum Pathol"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science (New York, N.Y.)"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nature Genetics"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat Genet"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"van Raamsdonk","year":"2010","journal-title":"N Engl J Med"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.1167\/iovs.08-2145","article-title":"Oncogenic mutations in GNAQ occur early in uveal melanoma","volume":"49","author":"Onken","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12672-022-00579-x","article-title":"BAP1 in cancer: epigenetic stability and genome integrity","volume":"13","author":"Caporali","year":"2022","journal-title":"Discov Oncol."},{"key":"bib12","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/bjc.2014.417","article-title":"Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing","volume":"111","author":"Kalirai","year":"2014","journal-title":"Br J Cancer"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1136\/bjophthalmol-2014-305047","article-title":"Prognostic parameters in uveal melanoma and their association with BAP1 expression","volume":"98","author":"van Essen","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"bib14","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000002176","article-title":"Prognostic value of BAP1 protein expression in uveal melanoma","author":"Kennedy","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000486370","article-title":"BAP1 immunostaining in uveal melanoma: potentials and pitfalls","volume":"4","author":"Herwig-Carl","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/cge.2018.93.issue-5","article-title":"Genetic and epigenetic insights into uveal melanoma","volume":"93","author":"Sharma","year":"2018","journal-title":"Clin Genet"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/cge.2012.81.issue-4","article-title":"Epigenetic modifications in cancer","volume":"81","author":"Kanwal","year":"2012","journal-title":"Clin Genet"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/febs.v289.5","article-title":"Mass spectrometry-based characterization of histones in clinical samples: applications, progress, and challenges","volume":"289","author":"Noberini","year":"2022","journal-title":"FEBS J"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-1804-1","article-title":"Cancer epigenetics: an introduction","volume":"1238","author":"Kanwal","year":"2015","journal-title":"Methods Mol Biol"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrm3890","article-title":"Histone core modifications regulating nucleosome structure and dynamics","volume":"15","author":"Tessarz","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","article-title":"Histone post-translational modifications - cause and consequence of genome function","volume":"23","author":"Mill\u00e1n-Zambrano","year":"2022","journal-title":"Nat Rev Genet."},{"key":"bib23","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.4049\/jimmunol.179.8.5317","article-title":"A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma","volume":"179","author":"Holling","year":"2007","journal-title":"J Immunol"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/1873-3468.12220","article-title":"PAUPAR lncRNA suppresses tumourigenesis by H3K4 demethylation in uveal melanoma","volume":"590","author":"Ding","year":"2016","journal-title":"FEBS Lett"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","article-title":"Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma","volume":"18","author":"Landreville","year":"2012","journal-title":"Clin Cancer Res"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2017.04.028","article-title":"In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor","volume":"400","author":"Wang","year":"2017","journal-title":"Cancer Lett"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.21873\/anticanres.12665","article-title":"The role of histone deacetylase inhibitors in uveal melanoma: current evidence","volume":"38","author":"Moschos","year":"2018","journal-title":"Anticancer Res"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-020-01173-x","article-title":"Verification of EZH2 as a druggable target in metastatic uveal melanoma","volume":"19","author":"Jin","year":"2020","journal-title":"Molec Cancer"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1074\/mcp.M115.054510","article-title":"Pathology tissue-quantitative mass spectrometry analysis to profile histone post-translational modification patterns in patient samples","volume":"15","author":"Noberini","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13148-021-01120-7","article-title":"Spatial epi-proteomics enabled by histone post-translational modification analysis from low-abundance clinical samples","volume":"13","author":"Noberini","year":"2021","journal-title":"Clin Epigenetics"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1.8.1","DOI":"10.1002\/0471143030.2014.63.issue-1","article-title":"Isolation, culture, and transfection of melanocytes","volume":"63","author":"Godwin","year":"2014","journal-title":"Curr Protoc Cell Biol"},{"key":"bib33","first-page":"103","article-title":"Differential responses of choroidal melanocytes and uveal melanoma cells to low oxygen conditions","volume":"23","author":"Weidmann","year":"2017","journal-title":"Mol Vis"},{"key":"bib34","first-page":"2210","article-title":"Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes","volume":"34","author":"Hu","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/pcr.2012.25.issue-2","article-title":"Genetic and molecular characterization of uveal melanoma cell lines","volume":"25","author":"Griewank","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000201566","article-title":"Novel cell lines derived by long-term culture of primary uveal melanomas","volume":"223","author":"Nareyeck","year":"2009","journal-title":"Ophthalmologica."},{"key":"bib37","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.exer.2006.04.004","article-title":"Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3","volume":"83","author":"Nareyeck","year":"2006","journal-title":"Exp Eye Res"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ijc.v62:2","article-title":"Establishment and characterization of an uveal-melanoma cell line","volume":"62","author":"de Waard-Siebinga","year":"1995","journal-title":"Int J Cancer"},{"key":"bib39","first-page":"3198","article-title":"Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma","volume":"32","author":"Ksander","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.molonc.2014.06.004","article-title":"Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target","volume":"8","author":"Amirouchene-Angelozzi","year":"2014","journal-title":"Mol Oncol"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1158\/1078-0432.CCR-09-3066","article-title":"Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and\/or metastatic tumors","volume":"16","author":"N\u00e9mati","year":"2010","journal-title":"Clin Cancer Res"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ymeth.2019.10.001","article-title":"Enrichment of histones from patient samples for mass spectrometry-based analysis of post-translational modifications","volume":"184","author":"Noberini","year":"2020","journal-title":"Methods (San Diego, Calif.)"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-0716-2863-8","article-title":"A super-SILAC approach for profiling histone posttranslational modifications","volume":"2603","author":"Noberini","year":"2023","journal-title":"Methods Mol Biol"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1021\/acs.jproteome.8b00133","article-title":"EpiProfile 2.0: a computational platform for processing epi-proteomics mass spectrometry data","volume":"17","author":"Yuan","year":"2018","journal-title":"J Proteome Res"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat Methods"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nbt.2839","article-title":"ProteomeXchange provides globally coordinated proteomics data submission and dissemination","volume":"32","author":"Vizca\u00edno","year":"2014","journal-title":"Nat Biotechnol"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1093\/nar\/gky224","article-title":"Extensive and systematic rewiring of histone post-translational modifications in cancer model systems","volume":"46","author":"Noberini","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/cancers11050723","article-title":"Profiling of epigenetic features in clinical samples reveals novel widespread changes in cancer","volume":"11","author":"Noberini","year":"2019","journal-title":"Cancers"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/ng1531","article-title":"Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer","volume":"37","author":"Fraga","year":"2005","journal-title":"Nat Genet"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1152\/physiolgenomics.00128.2020","article-title":"Methylation of histone 4's lysine 20: a critical analysis of the state of the field","volume":"53","author":"Corvalan","year":"2021","journal-title":"Physiol Genomics"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejca.2022.04.013","article-title":"In uveal melanoma Ga-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Ga-protein GNAQ mutations","volume":"170","author":"Piaggio","year":"2022","journal-title":"Eur J Cancer"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.exer.2019.04.001","article-title":"Spatial intratumor heterogeneity in uveal melanoma: tumor cell subtypes with a presumed invasive potential exhibit a particular epigenetic staining reaction","volume":"182","author":"Herwig-Carl","year":"2019","journal-title":"Exp Eye Res"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"1013475","DOI":"10.3389\/fgene.2022.1013475","article-title":"EZH2-mediated H3K27me3 is a predictive biomarker and therapeutic target in uveal melanoma","volume":"13","author":"Hou","year":"2022","journal-title":"Front Genet"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm.3947","article-title":"Loss of BAP1 function leads to EZH2-dependent transformation","volume":"21","author":"LaFave","year":"2015","journal-title":"Nat Med"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41467-018-08255-x","article-title":"BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylation","volume":"10","author":"Campagne","year":"2019","journal-title":"Nat Commun"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2478\/s11535-013-0141-1","article-title":"Heterogeneity of neural crest-derived melanocytes","volume":"8","author":"Cichorek","year":"2013","journal-title":"Open Life Sci"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1038\/sj.onc.1206460","article-title":"Development of melanocyte precursors from the vertebrate neural crest","volume":"22","author":"Dupin","year":"2003","journal-title":"Oncogene"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12094-008-0170-4","article-title":"Uveal vs. cutaneous melanoma. Origins and causes of the differences","volume":"10","author":"Belmar-Lopez","year":"2008","journal-title":"Clin Transl Oncol"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/pcr.1994.7.issue-2","article-title":"Interactions of melanocytes and melanoma cells with the microenvironment","volume":"7","author":"Herlyn","year":"1994","journal-title":"Pigment Cell Res"},{"key":"bib31","volume-title":"AJCC cancer staging manual","author":"Amin","year":"2017"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2793372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:51Z","timestamp":1791927111000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2793372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.65.2.27","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,13]]}}}